Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.
about
Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studiesBenzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysisInstrumental variable applications using nursing home prescribing preferences in comparative effectiveness researchQuantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Between Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residentsEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort studyInflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort studyReconsideration of key articles regarding medication-related problems in older adults from 2011.Mediators of First- Versus Second-generation Antipsychotic-related Mortality in Older Adults.Improving the management of behaviour that challenges associated with dementia in care homes: protocol for pharmacy-health psychology intervention feasibility study.Fracture risk in nursing home residents initiating antipsychotic medications.Antipsychotic and Benzodiazepine Drug Changes Affect Acute Falls Risk Differently in the Nursing Home.Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study.Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification.A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.Neuropsychiatric symptoms of dementia: consent, quality of life, and dignity.
P2860
Q26853714-45637FB8-1C6A-4B48-BD2F-9F59041E72B5Q33610208-CE567451-AFEB-4A39-98F1-5DAF2519E468Q33976565-062496FB-5F30-43E1-8219-2DAC06903D7CQ34070862-51424A66-B6DC-4B00-A615-F2473F03D2AAQ34452896-3BA77B18-4E8D-4E17-AE63-1AADD9E9C925Q34828456-DF039C0E-DA17-47F6-855A-CBE5E55EE6EEQ35754726-DA4459EE-FF9F-4E74-954F-4FD495A29D04Q35775454-5FF6DC66-DA60-4B2D-A16D-765993646FDCQ35946372-F3FD9A97-DD96-4E03-A1ED-0568504BF1A7Q36043785-B2EF5CE7-B0EE-4A94-A258-FE6232EBEE2FQ36482643-33FF0695-F025-432C-8698-1E281E94DFFBQ36732899-B142FAA5-F551-4AB5-9547-C00EAD28EEC0Q36849936-A096509A-1700-4A86-A5AC-BC1B3C47A518Q36939865-0D66B8E4-0842-4404-A0F4-D978170FAD07Q37156481-0342EE18-692A-4AE4-8B8E-0C45885DF74FQ37505818-B9E450EA-85C6-4502-9DB3-97CA2E5E4782Q37532386-5AFE158F-ACED-4FEA-AB90-E4E6BA547718Q37577329-EA481DED-BDBE-4F84-B0FB-FC20B096AE4DQ37693772-57BB928D-09D9-4EF3-80E2-545BF10E036EQ38324101-72419E00-99CE-4E82-869B-CC0235BAE0F3Q38998448-FDD76CCF-7354-43BE-939D-2A2E38A66BEBQ44175464-28F722CC-7DB4-454F-9E50-837F3DC1124AQ45066946-1BBE752E-358E-4F19-9DA1-155B65AD9FBBQ47555313-D40D691B-FA02-4E02-A3A1-B72B0ED05F44Q48063767-03F8C926-70A5-4952-AA64-2C2C230EB4E8Q52933114-2A34B0D8-5867-409A-9C87-878D43D7DDF1
P2860
Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk of death and hospital adm ...... lts admitted to nursing homes.
@ast
Risk of death and hospital adm ...... lts admitted to nursing homes.
@en
Risk of death and hospital adm ...... lts admitted to nursing homes.
@nl
type
label
Risk of death and hospital adm ...... lts admitted to nursing homes.
@ast
Risk of death and hospital adm ...... lts admitted to nursing homes.
@en
Risk of death and hospital adm ...... lts admitted to nursing homes.
@nl
prefLabel
Risk of death and hospital adm ...... lts admitted to nursing homes.
@ast
Risk of death and hospital adm ...... lts admitted to nursing homes.
@en
Risk of death and hospital adm ...... lts admitted to nursing homes.
@nl
P2093
P2860
P356
P1476
Risk of death and hospital adm ...... ults admitted to nursing homes
@en
P2093
Krista F Huybrechts
M Alan Brookhart
Sebastian Schneeweiss
P2860
P304
P356
10.1503/CMAJ.101406
P407
P577
2011-03-28T00:00:00Z